Whereas glucose-6-phosphate levels exhibited large variations during our analysis, the median value remained relatively stable.
Median SBP values remained within the prehypertensive range throughout the trial (120 139 mm Hg), while median DBP values stayed within the prehypertensive and upper normal range (75 89 mm Hg) (Table 2).
For all canakinumab doses ≥50 mg, median CRP values remained consistently lower than in the colchicine group throughout the study and were below the upper limit of the normal range (ULN, 3.0 mg/dl) up to week 24.
For both human and mouse, the median ISI values remain approximately equal when the reference point is located at 30~70% of the 5'UTR lengths from the 5' cap, but drop toward both ends of 5'UTR.
As expected, the medians of the MRI values remained stable with an increasing proportion of deleted sequences, whereas their range linearly increased (Figs. 5, 15 in supporting file S4); also, the medians of the MRI values linearly decreased with an increasing proportion of errors in the reference partition, whereas their range remained stable (Figs. 10, 20 in supporting file S4).
Whereas subsequent control uNGAL values remained low (median ranging from 0.02 to 0.1 ng/mg creatinine), AKI uNGAL concentrations were several fold higher than control uNGAL concentrations from days -2 to +2 (median [interquartile range] = 0.8 [2.0], 1.1 [2.0.7 0.6 [2.0], 0.6 [ 1], and 0.8 [ 1] ng/mg creatinine on days -2, -1, 0, +1, and +2, respectively; all P < 0.05 versus control).
In particular, bootstrap support values remained constant and high, with a median value of 100% in all An partitions (Additional File 5).
Production values remained luxurious.
In 149 participants, we substituted median values of the remaining participants for missing poverty income ratio, BMI, cotinine concentrations, or alcohol consumption.
Many of our values remain unconscious.
